Evidence map›Paper›PMID 28190771›Full record

ArticleCell metabolism2017

Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4

Claudio Mauro, Joanne Smith, Danilo Cucchi, David Coe, Hongmei Fu, Fabrizia Bonacina, Andrea Baragetti, Gaia Cermenati, Donatella Caruso, Nico Mitro and 6 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Cell metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 94 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03698383 phase2unknown statusnot on this mapstarted 2019, after this paper: background citation

Phase II Study of Trastuzumab Biosimilar (Herzuma®) Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer Who Progressed After 2 or More HER-2 Directed Chemotherapy

TypeinterventionalSponsorKorean Cancer Study GroupRan2019 to 2021Enrolled15ConditionsHER2-positive Breast Cancer, Metastatic Breast CancerArmsTrastuzumab biosimilars(Herzuma), Gedatolisib
NCT04480034 unknown statusnot on this mapstarted 2020, after this paper: background citation

Laparoscopic Bariatric Surgery During Phase 2-3 Covid-19 Pandemic in Italy: a Multicenter, Prospective, Observational Study.

TypeobservationalSponsorUniversity of Roma La SapienzaRan2020 to 2021Enrolled1,600ConditionsBariatric Surgery Candidate, Covid19, Complication of Surgical Procedure, Pneumonia, ViralArmsBariatric procedures
3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Obesity accelerates cardiovascular ageing.European heart journal · 2025
    Review
  12. Review
  13. Review
  14. Effect ofInternational journal of food science · 2025
    Article
  15. Review
  16. Review
  17. The influence of metabolic disorders on adaptive immunity.Cellular & molecular immunology · 2024
    Review
  18. Article
  19. Immunometabolism in atherosclerotic disorders.Nature cardiovascular research · 2024
    Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Claudio MauroWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK. Electronic address: c.mauro@qmul.ac.uk.
Joanne SmithWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
Danilo CucchiWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK; Istituto Pasteur, Fondazione Cenci Bolognetti, Rome 00161, Italy.
David CoeWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
Hongmei FuWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
Fabrizia BonacinaDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan 9-20133, Italy.
Andrea BaragettiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan 9-20133, Italy.
Gaia CermenatiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan 9-20133, Italy.
Donatella CarusoDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan 9-20133, Italy.
Nico MitroDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan 9-20133, Italy.
Alberico L CatapanoDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan 9-20133, Italy; IRCCS Multimedica, Milan 2-242091, Italy.
Enrico AmmiratiDe Gasperis Cardio Center, Niguarda Ca' Granda Hospital, Milan 3-20162, Italy.
Maria P LonghiWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
Klaus OkkenhaugLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, CB22 3AT, UK.
Giuseppe D NorataDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan 9-20133, Italy; School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia.
Federica M Marelli-BergWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK. Electronic address: f.marelli-berg@qmul.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BBS/E/B/000C0407Biotechnology and Biological Sciences Research Council BBS/E/B/000C0409British Heart Foundation CH/15/2/32064British Heart Foundation FS/11/64/28945British Heart Foundation FS/12/38/29640British Heart Foundation FS/13/49/30421British Heart Foundation PG/15/105/31906British Heart Foundation RG/14/2/30616Medical Research Council MR/P021220/1
6 · The paper itself

Abstract

Low-grade systemic inflammation associated to obesity leads to cardiovascular complications, caused partly by infiltration of adipose and vascular tissue by effector T cells. The signals leading to T cell differentiation and tissue infiltration during obesity are poorly understood. We tested whether saturated fatty acid-induced metabolic stress affects differentiation and trafficking patterns of CD4

Indexed as

Cell DifferentiationImmunologic MemorySignal TransductionStress, PhysiologicalAdiposityAnimalsAntigen PresentationCD4-Positive T-LymphocytesCell MovementDendritic CellsDiet, High-FatFatty AcidsFemaleHumansInflammationLymphocyte ActivationCXCR3 protein, humanFatty AcidsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, CXCR3AktCD4differentiationeffector memoryhigh-fat dietinflammationobesitypalmitatesaturated fatty acidT lymphocyte

Identifiers

PMID28190771
PMCPMC5355363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.